Clinical Trials Directory

Trials / Completed

CompletedNCT02365363

PERFECT Project - Part 2 - Study 3

Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 3

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objectives are to test the acute effects of different bagels containing pulse ingredients on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite to an aerobic exercise session, and 3) food intake two hours following the exercise session. We hypothesize that consumption of bagels containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. We also hypothesize that consumption of bagels containing pulse ingredients will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.

Conditions

Interventions

TypeNameDescription
OTHERControlNon pulse ingredient bagel
OTHERPea flourPulse ingredient bagel
OTHERPea fibrePulse ingredient bagel
OTHERPea flour and pea fibrePulse ingredient bagel
OTHERPea flour and pea proteinPulse ingredient bagel
OTHERPea flour + pea fibre + pea proteinPulse ingredient bagel

Timeline

Start date
2016-10-01
Primary completion
2017-12-19
Completion
2017-12-19
First posted
2015-02-18
Last updated
2023-01-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02365363. Inclusion in this directory is not an endorsement.